FP7Реинтеграция2013–2017

LABCAXPCI · Laboratory- Based Coded Aperture X-ray Phase-Contrast Imaging

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2013-06-01 → 2017-05-31
Финансиране от ЕС
100 000 €
Участници
1
Схема
MC-CIG

Линиите свързват координатора с партньорите.

Накратко на български

Рентгеновото изображения с фазов контраст се подобрява чрез нови методи за заснемане, които да работят в лаборатории, заводи или болници. Това помага за създаването на по-прецизни системи за диагностика и индустриален контрол.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Laboratory- Based Coded Aperture X-ray Phase-Contrast Imaging

The aim of the LaBCAXPCI project was to make X-ray Phase-Contrast Imaging techniques more powerful and flexible, completing their translation into real-life applications with the deployment of new experimental methods that are fully compatible with a laboratory, industrial or clinical environment. LabCAXPCI has progressed as planned for this reporting period, with the development of a high-magnification CAXPCI system, a system capable of 2D sensitivity and a method for laboratory-based hard-X-ray dark-field imaging. The first three objectives of the project were successfully completed and the obtained results were published (or are going to be submitted in the near future). In addition to the scientific output presented on scientific journals and at international conferences, one patent was filed which serves as the basis for the continuation of a fruitful collaboration with industry. The collaboration network was also expanded with new connections within the Host Institution where overlapping area of interest were identified. The fellow also started to develop new skills by supervising and co-supervising undergraduate, masters and PhD students. The fellow was also successful in securing a five-year Royal Academy of Engineering Research Fellowship for exploring the applications of the novel imaging methods that are under development within LabCAXPCI and maximising their expansion and impact. All these elements are contributing to the integration of the fellow and towards the consolidation of him as a scientist in cutting edge X-ray imaging research and its interdisciplinary applications.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Aim of the LaBCAXPCI project is to make X-ray Phase-Contrast Imaging techniques more powerful and flexible, completing their translation into real-life applications with the deployment of new experimental methods that are fully compatible with a laboratory, industrial or clinical environment. Proof of principle experiments [1] have recently demonstrated that Coded Aperture system are capable of quantitative X-ray Phase-Contrast Imaging with practically no coherence conditions, opening the possibility for the full translation of the high potential of X-ray Phase-Contrast Imaging (i.e. high-magnification imaging, imaging with phase sensitivity in two orthogonal directions simultaneously, dark-field imaging and fully three-dimensional imaging). The completion of LaBCAXPCI will ultimately enable the delivery of better images to a number of people as large as possible. X-ray Phase-Contrast Imaging has a wide range of applications in medicine, biology and material science [2- 6]. Examples of applications that will take advantage of the completion of LaBCAXPCI are: non-destructive testing [7-9], homeland security [10], small animal imaging [11-14], non-calcified tissue [15,16] and breast imaging [17,18].[1] P. R.T. Munro et al, PNAS 109 (35):13922; [2] T. J. Davis et al, Nature 373, 595; [3] S. W. Wilkins et al, Nature 384, 335; [4] R. Fitzgerald, Physics Today 53(7), 23; [5] F. Pfeiffer et al, Nature Physics 2, 258; [6] R A Lewis, Phys Med Biol 49 3573; [7] B. Zoofan et al, J. Appl. Phys. 100, 014502; [8] S. C. Mayo et al, Materials 5(5), 937; [9] A. W. Stevenson et al, NIM B, 99:427; [10] A. Olivo et al, NIM A, 610, 604; [11] P. Coan et al, Phys. Med. Biol. 55 7649; [12] A. Momose et al, Radiology 217(2):593; [13] T. Takeda et al, Circulation 105:1708; [14] M. J. Kitchen et al, Eur J Radiol 68 (3), S49; [15] P. Coan et al, Invest Radiol 45(7):437; [16] J Li et al, J Anat 202(5):463; [17] Arfelli et al, Radiology 215:1,286; [18] E. Castelli et al, Radiology 259:3

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз